Acute myeloid leukemia (AML) arise from mutations of stem and progenitor cells. Here, authors identify a quiescent, label-retaining cell population in AML patient specimens that have tumor-initiation capacity and unique epigenetic and transcriptional properties that can be functionally altered by expression of transcription factors such as JUN.
- Sumiko Takao
- Victor Morell
- Alex Kentsis
